Importance of propionate for the repression of hepatic lipogenesis and improvement of insulin sensitivity in high-fat diet-induced obesity

Mol Nutr Food Res. 2016 Dec;60(12):2611-2621. doi: 10.1002/mnfr.201600305. Epub 2016 Aug 30.

Abstract

Scope: The SCFA acetate (Ac) and propionate (Pr) are major fermentation products of dietary fibers and provide additional energy to the host. We investigated short- and long-term effects of dietary Ac and Pr supplementation on diet-induced obesity and hepatic lipid metabolism.

Methods and results: C3H/HeOuJ mice received high-fat (HF) diets supplemented with 5% SCFA in different Ac:Pr ratios, a high acetate (HF-HAc; 2.5:1 Ac:Pr) or high Pr ratio (HF-HPr; 1:2.5 Ac:Pr) for 6 or 22 weeks. Control diets (low-fat (LF), HF) contained no SCFA. SCFA did not affect body composition but reduced hepatic gene and protein expression of lipogenic enzymes leading to a reduced hepatic triglyceride concentration after 22 weeks in HF-HPr mice. Analysis of long-chain fatty acid composition (liver and plasma phospholipids) showed that supplementation of both ratios led to a lower ω6:ω3 ratio. Pr directly led to increased odd-chain fatty acid (C15:0, C17:0) formation as confirmed in vitro using HepG2 cells. Remarkably, plasma C15:0 was correlated with the attenuation of HF diet-induced insulin resistance.

Conclusion: Dependent on the Ac:Pr ratio, especially odd-chain fatty acid formation and insulin sensitivity are differentially affected, indicating the importance of Pr.

Keywords: Acetate; Energy metabolism; High-fat diet; Obesity; Propionate; SCFA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetates / pharmacology
  • Animals
  • Blood Glucose / metabolism
  • Body Composition
  • Diet, Fat-Restricted
  • Diet, High-Fat / adverse effects
  • Dietary Fats / administration & dosage
  • Dietary Supplements
  • Fatty Acids, Omega-3 / blood
  • Fatty Acids, Omega-6 / blood
  • Hep G2 Cells
  • Humans
  • Insulin Resistance*
  • Lipogenesis / drug effects*
  • Liver / drug effects*
  • Liver / metabolism
  • Male
  • Mice
  • Mice, Inbred C3H
  • Obesity / drug therapy*
  • Propionates / pharmacology*
  • Triglycerides / blood

Substances

  • Acetates
  • Blood Glucose
  • Dietary Fats
  • Fatty Acids, Omega-3
  • Fatty Acids, Omega-6
  • Propionates
  • Triglycerides